Natural Products
| Catalog No. | Information |
| CFN00105 | Antibiotic 2158 Antibiotic 2158 is a PAF synthesis inhibitor. |
| CFN00106 | Antibiotic AB 4015B Antibiotic AB 4015B is active against bacteria and fungi. |
| CFN00107 | Antibiotic AB 4063B Antibiotic AB 4063B is active against phytopathogenic fungi. |
| CFN00108 | Antibiotic PF 1052 Antibiotic PF 1052 is an antibacterial agent. |
| CFN00109 | Apiodionene Reference standards. |
| CFN00110 | Blasticidin A Blasticidin A, an antibiotic produced by Streptomyces, almost completely inhibit aflatoxin production at 0.5 microM, significantly reduces the expression of genes encoding aflatoxin biosynthetic enzymes (pksA, ver-1 and omtA) and a regulatory gene (aflR) in A. parasiticus. |
| CFN00111 | Bripiodionene Bripiodionen is a human cytomegalovirus protease inhibitor, it displays inhibitory activity against human cytomegalovirus protease with an IC50 value of 30 microM. |
| CFN00112 | Cylindramide Cylindramide is cytotoxic against B16 melanoma cells with an IC50 of 0.8 ug/m, it shows promising antiproliferative activity against several tumour cell lines. (+)-Cylindramide has anti-microbial properties. |
| CFN00113 | Delaminomycin A Delaminomycin A is an immunomodulator, it is a cell adhesion inhibitor and extracellular matrix receptor antagonist. Delaminomycin A is active against gram-positive bacteria. |
| CFN00114 | Discodermide Discodermide has antifungal and cytotoxic activities. |
| CFN00115 | Equisetin Equisetin has antibacterial activity, the MIC's for Equisetin are 8 ug /mL against Bacillus subtilis, 16 ug /mL against Staphylococcus aureus and Methicillin Resistant Staphylococcus aureus (MRSA).Equisetin inhibits the DNP-stimulated ATPase activity of rat liver mitochondria and mitoplasts in a concentration-dependent manner; 50% inhibition is caused by about 8 nmol Equisetin/mg protein.It also specifically inhibits the substrate anion carriers of the mitochondrial inner membrane. |
| CFN98897 | Lycernuic acid A Reference standards. |
| CFN98898 | Onitin Onitin shows super-oxide and DPPH free radical scavenging effects.It also exhibits hepatoprotective activity on tacrine-induced cytotoxicity in human liver-derived Hep G2 cells. |
| CFN98899 | Onitisin Onitisin, onitinoside and onitin can inhibit the contraction of isolated guinea-pig ileum. |
| CFN98900 | Flavaprin Reference standards. |
| CFN98901 | Caboxine A Standard reference |
| CFN98902 | Corylin Corylin has a variety of pharmacological effects such as antioxidant, anti-proliferation, and anti-inflammatory properties, it may stimulate bone formation or have potential activity against osteoporosis. Corylin shows an inhibitory effect on IL-6-induced STAT3 promoter activity in Hep3B cells. |
| CFN98903 | Aristolactam BII Aristolactam BII exhibits antimicrobial and antiinflammatory activity, it shows significant activity towards DPPH radical scavenging and potent inhibitory effects against tyrosinase mushroom. Aristolactam BII also exerts its significant neuroprotective effects on glutamate-injured primary cultures of rat cortical cells by directly inhibiting the production of nitric oxide. |
| CFN98904 | Aristolactam BIII Aristolactam BIII possesses anti-platelet aggregation activity in vitro, it also shows significant cytotoxic activity (IC50 values < 4 microg/mL) against P-388, HT-29 and A549 cell lines in vitro. |
| CFN98905 | Isoastilbin Isoastilbin has anti-acne and tyrosinase inhibition properties.Isoastilbin, neoastilbin, astilbin and taxifolin have antimicrobial activities, they depress the growth of Streptococcus sobrinus (S. sobrinus) over a concentration range of 9.32-42.7 ug/ml and show GTase inhibitory activity with IC50 values in the range 27.4-57.3 ug/ml. |
| CFN98906 | 15-Hydroxydehydroabietic acid 15-Hydroxydehydroabietic acid exhibits a promising alpha-glucosidase inhibitory activity, it also shows significant antibacterial activities. |
| CFN00116 | Erythroskyrin Erythroskyrin is a kind of mycotoxin. |
| CFN00117 | Fuligorubin A Reference standards. |
| CFN00118 | Harzianic acid Harzianic acid is a Trichoderma secondary metabolite, it shows plant growth promotion activity. Harzianic acid has antifungal activity and antibiotic activity against Pythium irregulare, Sclerotinia sclerotiorum, and Rhizoctonia solani. |
| CFN00119 | Isodomoic acid G Reference standards. |
| CFN00120 | Janolusimide Janolusimide is a neurotoxin and atropine antagonist. |
| CFN00121 | Lactacystin Lactacystin is a selective UPS inhibitor recently used to destroy dopamine (DA) neurons in animal models of Parkinson's disease (PD); marked differences in the rotational response to apomorphine and l-DOPA suggest different mechanisms of neurodegeneration evoked by Lactacystin and 6-OHDA. Lactacystin induces cell death and α-synuclein-positive inclusions in cytoplasm, it has diversified killing effects on gastric cancer cells, the mechanism may be related to induce the apoptosis by downregulation of nuclear factor kappa B viability. |
| CFN00122 | alpha-Lipomycin Alpha-Lipomycin belongs to the classification of hybrid peptide-polyketide natural products. Alpha-Lipomycin is active against gram-positive organisms. |
| CFN00123 | Lydicamycin Lydicamycin is active against Gram-positive bacteria and a certain yeast. |
| CFN00124 | Malonomicin Malonomicin has inhibitory effects on gram-positive organisms. |
| CFN00125 | Nocamycin I Nocamycin I shows potent antimicrobial activity and it holds great potential for antibacterial agent design. |
| CFN00126 | Antibiotic BU 2313A Antibiotic Bu-2313 A and Antibiotic Bu-2313 B each exhibit a broad antibiotic spectrum against Gram-positive and Gram-negative anaerobic bacteria, and show in vivo activity against experimental infections produced by B. fragilis and C. perfringens. |
| CFN00127 | Nortenuazonic acid Reference standards. |
| CFN00128 | Oleficin Oleficin, a polyene antibiotic, it is active against Grampositive bacteria and has no effect upon the growth of fungi and yeasts.Oleficin has effects on mitochondrial functions can be explained on the basis of an increase of the inner membrane permeability as the consequence of the depletion of Mg2+ from mitochondria caused by the antibiotic. It could as an ionophore of Mg2+ in isolated rat liver mitochondria, preferentially inhibit growth of the yeast Saccharomyces cerevisiae on non-fermentable substrates. |
| CFN00129 | Oteromycin Oteromycin is a inhibitor of HIV-1 integrase. |
| CFN00130 | Antibiotic ZG 1494alpha Antibiotic ZG 1494alpha is a novel inhibitor of platelet-activating factor (PAF) acetyltransferase. It also exhibits antifungal activity against Candida albicans. |
| CFN98907 | 2-(1-Hydroxy-1-methylethyl)-4-methoxy-7H-furo[3,2-g][1]benzopyran-7-one Reference standards. |
| CFN98908 | 2',4'-Dihydroxy-3',6'-dimethoxydihydrochalcone Reference standards. |
| CFN98909 | Decarine Decarine has high antibacterial activity against mycobacterial, gram-positive and gram-negative bacteria, and low cytotoxicity towards human macrophages.Decarine inhibits fMLP/CB-induced elastase release with IC(50) values < or = 5.53 microg/mL. |
| CFN98910 | 7-Hydroxy-5,8-dimethoxyflavanone Standard reference |
| CFN98911 | 5-Glutinen-3-ol 5-Glutinen-3-ol is a natural product from Clausena excavata. |
| CFN98912 | Uvaol Uvaol has anti-inflammatory, anti-proliferative, and vasorelaxing activities. Uvaol reduces cardiac hypertrophy and left ventricle remodeling induced by angiotensin II in mice by diminishing fibrosis and myocyte area; it inhibits the angiotensin II-induced proliferation in a PPAR-γ-dependent manner, while at high doses they activate pathways of programmed cell death that are dependent on JNK and PPAR-γ. |
| CFN98913 | Lupeol 1. Lupeol has a potential to act as an anti-inflammatory, anti-microbial, anti-protozoal, anti-proliferative, anti-invasive, anti-angiogenic, antimalarial and cholesterol lowering agent. 2. Lupeol prevents acetaminophen-induced in vivo hepatotoxicity by altering the Bax/Bcl-2 and oxidative stress-mediated mitochondrial signaling cascade. 3. Lupeol and its ester derivative have beneficial effects on hypercholesterolemia-induced oxidative and inflammatory stresses. 4. Lupeol significantly enhances the radiosensitivity of SMMC-7721 cells in vitro and in vivo. 5. Lupeol shows antidiabetic and antioxidant potential in experimental hyperglycaemia. 6. Lupeol has potential anticancer effect against hepatocellular and pancreatic cancer, by inhibiting cell proliferation, inducing apoptosis and blocking Akt/PI3K and Wnt signaling pathway. 7. Lupeol has antiangiogenic effects, it (at 50 and 30 microg/mL) shows a marked inhibitory activity on human umbilical venous endothelial cells (HUVEC) tube formation while it does not affect the growth of tumor cell lines such as SK-MEL-2, A549, and B16-F10 melanoma. |
| CFN98914 | Erythrodiol Erythrodiol is the precursor of pentacyclic triterpenic acids, it exerts antiproliferative and proapoptotic activity in colon adenocarcinoma cells. Erythrodiol may have interesting therapeutic potential as new vasodilator drugs, thus protecting the cardiovascular system. |
| CFN98915 | Isolariciresinol Isolariciresinol has antioxidant and anti-inflammatory activities during an in vitro gastro-intestinal digestion of the Radix Isatidis extract (RIE). |
| CFN98916 | Roseoside Roseoside possesses strong antioxidant properties, inhibiting lipid oxidation by 86.4, at 50 microg/mL. Roseoside has insulinotropic activity, enhances insulin release from the β-cell line INS-1.Roseoside can significantly delay carcinogenesis induced by peroxynitrite (initiator) and TPA (promoter). (6S,9R)-Roseoside also can inhibit the histamine release from rat peritoneal exudate cells induced by antigen-antibody reaction. |
| CFN00131 | Physarorubinic acid A Reference standards. |
| CFN00132 | Polycephalin C Reference standards. |
| CFN00133 | Pramanicin Pramanicin, an antimicrobial agent, has vasorelaxant effect, it induces a slow endothelium-dependent relaxation, which could be reversed with the NO synthase inhibitor, L-NOARG, it has potent, selective, and irreversible inhibitory effect on the endothelial.Pramanicin as a potential apoptosis-inducing small molecule, which acts through a well-defined JNK- and p38-dependent apoptosis signalling pathway in Jurkat T leukemia cells. |
| CFN00134 | Preapiodionene Reference standards. |
